t rFSH derived from a human cell line (PER.C6®cell line). Follitropin delta is structurally and biochemically distinct from other existing rFSH gonadotrophins.3,4Follitropin delta is approved in certain markets for use in controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (ART), such as IVF or ICSI cycle. The individualised dosing of follitropin delta is determined using an approved algorithm, based on a woman’s AMH level and body weight.3,5AMH is a biomarker used to assess ovarian reserve and can help predict ovarian response.5,6The follitropin delta dose should be based on AMH level, measured using the ELECSYS AMH Plus immunoassay from Roche, the ACCESS AMH Advanced from Beckman Coulter, or LUMIPULSE G AMH from Fujirebio.3

About Ferring Pharmaceuticals

Ferring Pharmaceuticals is a privately owned, research-driven, specialty biopharmaceutical group committed to building families
=*=*=*=*=*=
当前为第5/8页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页